Drug Database
Back to search

Switzerland· 59174002

Afinitor

A everolimus product containing everolimusum, registered in Switzerland and dispensed under Swissmedic category A, on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat A (Swissmedic)ATC L01EG02

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedAfinitorATCL01EG02REGISTER NO.59174002PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about everolimusumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Everolimus is registered in 11 of 19 countries.

Countries holding a registration under ATC L01EG02 (everolimus), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 8 of them publish a price we can compare per daily dose
Search everolimus products by name

Everolimus · ATC L01EG02

11 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of everolimus costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $27.93 in United States to $142.94 in Switzerland — a ×5.1 gap.

  • Switzerland: $142.94 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Everolimus · price per daily dose (10 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$142.94
  • IT Italy$125.91
  • ES Spain$105.57
  • US United States$27.93 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
everolimusum
Manufacturer
—
Country
Switzerland (CH)
ATC code
L01EG02
ATC class
Everolimus
Defined daily dose
10 mg, O
Swissmedic category
A
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680591740023
    30 Stk
    CHF 1640.9

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

428 interactions on record for everolimus.

Graded by severity as the source publishes them — 165 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check everolimus against other medicinesHow interaction checks work

Everolimus · interactions on record

428 records

  • 165 severe
  • 255 moderate
  • 8 minor

Most severe, free to view

  • AprepitantA04AD12severe
  • NeomycinA07AA01severe
  • StreptomycinA07AA04severe
  • Polymyxin BA07AA05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Everolimus in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All everolimus products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Certican, Everolimus Ethypharm
  • Belgium · Certican, Everolimus Eg
  • Bulgaria · Еверолимус Крка, Еверолимус Майлан
  • Cyprus · Certican, Everolimus Pharmazac
  • Czechia · Certican, Everolimus Accord
  • Germany · Certican, Everofin
  • Denmark · Certican, Everolimus Krka
  • Estonia · Certican, Everolimus Krka
  • Spain · Certican, Everolimus Accord
  • Finland · Aderolio, Certican
  • France · Certican, Everolimus Arrow
  • United Kingdom (Northern Ireland) · Aderolio, Aderolio 250 Mcg Tablets
  • Greece · Certican, Everolimus Faran
  • Croatia · Certican, Everolimus Krka
  • Hungary · Certican, Everolimus Accord
  • Ireland · Certican, Everolimus Tad
  • Iceland · Afinitor, Certican
  • Italy · Certican, Everolimus Accord
  • Liechtenstein · Afinitor, Votubia
  • Lithuania · Certican, Everolimus Norameda
  • Luxembourg · Certican, Everolimus Eg
  • Latvia · Certican, Everolimus Norameda
  • Malta · Certican, Everolimus Ascend
  • Netherlands · Certican, Certican Dispers
  • Norway · Afinitor, Certican
  • Poland · Aderolio, Certican
  • Portugal · Certican, Everolimus Ethypharm
  • Romania · Certican, Everolimus Accord
  • Sweden · Certican, Everolimus Avansor
  • Slovenia · Certican, Everolimus Krka
  • Slovakia · Certican, Everolimus Accord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d0a60957-b59d-4e7d-8f6e-9faa64f953db
GET /v1/drugs/d0a60957-b59d-4e7d-8f6e-9faa64f953db?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "everolimusum 10 mg",
  "valid_from": "2010-02-01",
  "limitations": "[{\"description\":\"Behandlung von Patienten mit fortgeschrittenem Nierenzellkarzinom nach Versagen einer Behandlung mit Sunitinib.<br>\\nBehandlung von Patienten mit fortgeschrittenen, progredienten, gut oder mässig differenzierten neuro-endokrinen Tumoren pankreatischen Ursprungs.<br>\\nIn Kombination mit Exemestan zur Behandlung von postmenopausalen Frauen mit fortgeschrittenem, hormonrezeptor positivem, HER2 negativem Brustkrebs nach Versagen einer Behandlung mit Letrozol oder Anastrozol.<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2024-03-01\",\"validTo\":null}]",
  "galenic_form": "Tabl 10 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2010-02-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about everolimus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console